Profiling Program of Advanced/Metastatic Pancreatic Cancer Patients
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-05-18
- Last Posted Date
- 2023-07-12
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 750
- Registration Number
- NCT05380414
- Locations
- 🇫🇷
Centre Léon Bérard, Lyon, France
Personalised Primary Prevention Intervention for Vulnerable Informal Caregivers at Increased Risk of Cancer
Recruiting
- Conditions
- First Posted Date
- 2022-04-04
- Last Posted Date
- 2023-04-04
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 130
- Registration Number
- NCT05310045
- Locations
- 🇫🇷
Centre Leon Berard, Lyon, France
Feasibility Study to Assess an Adapted Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Transplantation
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-03-28
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 15
- Registration Number
- NCT05298930
- Locations
- 🇫🇷
Institut d'Hématologie et d'Oncologie Pédiatrique, Lyon, France
Lifestyle Intervention After Colonoscopy (LIFE-SCREEN Pilot)
- First Posted Date
- 2022-03-10
- Last Posted Date
- 2024-02-12
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 24
- Registration Number
- NCT05273931
- Locations
- 🇫🇷
Centre Léon Bérard, Lyon, France
🇫🇷Hôpital Edouard Herriot (HCL), Lyon, France
Economic Evaluation of Sarcoma Patients Management in France
- Conditions
- Interventions
- First Posted Date
- 2022-03-09
- Last Posted Date
- 2022-03-09
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 2431
- Registration Number
- NCT05272358
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
🇫🇷Centre Leon Berard, Lyon, France
🇫🇷Centre François Baclesse, Caen, France
Evaluation of Percutaneous Cryotherapy in the Treatment of Plexiform Neurofibromas and Unresectable Neurofibromas in Neurofibromatosis Type 1
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-01-20
- Last Posted Date
- 2024-02-09
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 30
- Registration Number
- NCT05199376
- Locations
- 🇫🇷
Centre Leon Berard, Lyon, France
HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue Sarcomas
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-01-06
- Last Posted Date
- 2024-04-08
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 58
- Registration Number
- NCT05180695
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, France
🇫🇷Institut Paoli-Calmettes, Marseille, France
🇫🇷Institut Claudius Regaud, Toulouse, France
A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments
- First Posted Date
- 2021-12-09
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 110
- Registration Number
- NCT05152472
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
🇫🇷Institut Bergonié, Bordeaux, France
🇫🇷CHU Poitiers, Poitiers, France
Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET)
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-10-29
- Last Posted Date
- 2022-07-05
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 500
- Registration Number
- NCT05099068
- Locations
- 🇫🇷
Centre Léon Bérard, Lyon, France
🇫🇷HOPITAL Pierre WERTHEIMER - HCL, Bron, France
Axitinib +/- Pembrolizumab in First Line Treatment of mPRCC
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-10-27
- Last Posted Date
- 2024-01-25
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 72
- Registration Number
- NCT05096390
- Locations
- 🇫🇷
Ico - Paul Papin, Angers, France
🇫🇷CHU de BESANCON, Besançon, France
🇫🇷Chu Bordeaux, Bordeaux, France
© Copyright 2024. All Rights Reserved by MedPath